| Immunotherapy for colorectal cancer: a review of current and novel therapeutic approaches AJ Franke, WP Skelton IV, JS Starr, H Parekh, JJ Lee, MJ Overman, ... JNCI: Journal of the National Cancer Institute 111 (11), 1131-1141, 2019 | 152 | 2019 |
| Total neoadjuvant therapy: a shifting paradigm in locally advanced rectal cancer management AJ Franke, H Parekh, JS Starr, SA Tan, A Iqbal, TJ George Jr Clinical colorectal cancer 17 (1), 1-12, 2018 | 114 | 2018 |
| Management of malignant bowel obstruction associated with GI cancers AJ Franke, A Iqbal, JS Starr, RM Nair, TJ George Jr Journal of oncology practice 13 (7), 426-434, 2017 | 84 | 2017 |
| Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients R Bishnoi, R Bajwa, AJ Franke, WP Skelton, Y Wang, NM Patel, ... Experimental Hematology & Oncology 6, 1-14, 2017 | 56 | 2017 |
| Role of bevacizumab for treatment-refractory meningiomas: A systematic analysis and literature review AJ Franke, WP Skelton IV, LE Woody, A Bregy, AH Shah, K Vakharia, ... Surgical neurology international 9, 2018 | 32 | 2018 |
| National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer TJ George, AJ Franke, AB Chakravarthy, P Das, A Dasari, BF El‐Rayes, ... Cancer 125 (16), 2732-2746, 2019 | 24 | 2019 |
| The role of radiation therapy in pancreatic ductal adenocarcinoma in the neoadjuvant and adjuvant settings AJ Franke, LM Rosati, TM Pawlik, R Kumar, JM Herman Seminars in oncology 42 (1), 144-162, 2015 | 23 | 2015 |
| Investigation of complications following port insertion in a cancer patient population: a retrospective analysis WP Skelton IV, AJ Franke, S Welniak, RC Bosse, F Ayoub, M Murphy, ... Clinical Medicine Insights: Oncology 13, 1179554919844770, 2019 | 16 | 2019 |
| Management of malignant bowel obstruction associated with GI cancers. J Oncol Pract.(2017) 13: 426–34. doi: 10.1200 AJ Franke, A Iqbal, JS Starr, RM Nair, TJ George JOP, 2017 | 11 | 2017 |
| Results of a phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response pathway deficient neoplasms. TJ George, JH Lee, PJ Hosein, DL DeRemer, JA Chatzkel, ... Journal of Clinical Oncology 40 (16_suppl), 3122-3122, 2022 | 10 | 2022 |
| A comprehensive review of randomized clinical trials shaping the landscape of rectal cancer therapy AJ Franke, WP Skelton IV, TJ George, A Iqbal Clinical Colorectal Cancer 20 (1), 1-19, 2021 | 10 | 2021 |
| Comprehensive literature review of randomized clinical trials examining novel treatment advances in patients with colon cancer WP Skelton IV, AJ Franke, A Iqbal, TJ George Journal of Gastrointestinal Oncology 11 (4), 790, 2020 | 9 | 2020 |
| Pericardial effusion as an atypical initial presentation of extra-gonadal nonseminomatous germ cell tumor: a case report and literature review WP Skelton, D Mahtta, S Welniak, AJ Franke, LH Dang Oxford medical case reports 2018 (2), omx097, 2018 | 9 | 2018 |
| Single-Institution retrospective analysis of prognostic factors influencing very late-onset post-transplant lymphoproliferative disorder R Bishnoi, J Minish, AJ Franke, WP Skelton IV, CP Shah, Y Wang, ... Cureus 12 (2), 2020 | 8 | 2020 |
| Post transplant lymphoproliferative disorder risk factors in children: analysis of a 23‐year single‐institutional experience RC Bosse, AJ Franke, W Paul Skelton IV, LE Woody, R Bishnoi, Y Wang, ... Pediatric Transplantation 24 (5), e13747, 2020 | 7 | 2020 |
| Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomes K Pan, AJ Franke, WP Skelton IV, R Bishnoi, C Shah, NH Dang, ... Leukemia & lymphoma 62 (5), 1123-1128, 2021 | 5 | 2021 |
| Differences in the characteristics of younger and older MSI-H colorectal cancer (CRC) as determined by universal reflex testing. AJ Franke, WP Skelton, M Gaffar, F Lutfi, S Welniak, M Feely, JS Starr, ... Journal of Clinical Oncology 36 (15_suppl), 3593-3593, 2018 | 5 | 2018 |
| A multi-center retrospective analysis examining the effect of dipeptidyl peptidase-4 inhibitors on progression-free survival in patients with prostate cancer K Pan, WP Skelton, M Elzeneini, TC Nguyen, AJ Franke, A Ali, R Bishnoi, ... Cureus 13 (4), 2021 | 4 | 2021 |
| Impact of institutional universal microsatellite-instability (MSI) reflex testing on molecular profiling differences between younger and older patients with colorectal cancer E Altshuler, AJ Franke, WP Skelton IV, M Feely, Y Wang, JH Lee, T Read, ... Clinical Colorectal Cancer 22 (1), 153-159, 2023 | 3 | 2023 |
| Prognostic value of CA 19-9 and carcinoembrionic antigen (CEA) in duodenal adenocarcinoma (DA): An institutional retrospective cohort study. E Altshuler, W King, R Richhart, K Hones, A Mathavan, A Mathavan, ... Journal of Clinical Oncology 40 (16_suppl), e16306-e16306, 2022 | 3 | 2022 |
